Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +2.94% | -4.37% | +209.73% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+209.73% | 32Cr | |
+37.74% | 72TCr | |
+32.22% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+16.60% | 24TCr | |
+9.77% | 21TCr | |
-5.15% | 21TCr | |
+7.43% | 17TCr |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Benchmark Upgrades Nektar Therapeutics to Buy From Hold; Price Target is $20